Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shelly L Gray

Showing results (11-20 of 131) with videos related to

Pageof 14
Sort By:
The American Journal of Geriatric Pharmacotherapy|November 24, 2004
Can clinical pharmacy services have a positive impact on drug-related problems and health outcomes in community-based older adults?Joseph T Hanlon, Catherine I Lindblad, Shelly L Gray
The American Journal of Geriatric Pharmacotherapy|November 24, 2004
Zolpidem prescribing and adverse drug reactions in hospitalized general medicine patients at a Veterans Affairs hospitalJane E Mahoney, Melissa J Webb, Shelly L Gray
The American Journal of Geriatric Pharmacotherapy|November 8, 2011
Medication use and functional status decline in older adults: a narrative reviewEmily P Peron, Shelly L Gray, Joseph T Hanlon
Journal of Managed Care & Specialty Pharmacy|December 24, 2025
Health care resource utilization and costs of commercially insured US patients with atopic dermatitis switching from first-line to second-line systemic targeted therapiesKevin H Li, Shelly L Gray, Sean D Sullivan
Pharmacoepidemiology and Drug Safety|August 28, 2020
Alzheimer's disease and related dementias risk: Comparing users of non-selective and M3-selective bladder antimuscarinic drugsDouglas Barthold, Zachary A Marcum, Shelly L Gray, et al.
Drugs & Aging|September 13, 2023
Systematic Review and Meta-analysis of Interventions to Reduce Adverse Drug Reactions in Older Adults: An UpdateShelly L Gray, Subashan Perera, Tim Soverns, et al.
ACR Open Rheumatology|October 24, 2022
Optimizing Medication Use in Older Adults With Rheumatic Musculoskeletal Diseases: Deprescribing as an Approach When Less May Be MoreJiha Lee, Namrata Singh, Shelly L Gray, et al.
Drugs & Aging|February 5, 2021
Interventions to Reduce Fall-Risk-Increasing Drug Use to Prevent Falls: A Narrative Review of Randomized TrialsShelly L Gray, Zizi Elsisi, Elizabeth A Phelan, et al.
Journal of the American Geriatrics Society|December 1, 2023
Medication use quality and safety in older adults: 2022 updateShelly L Gray, Nicole Brandt, Kenneth E Schmader, et al.
The American Journal of Geriatric Pharmacotherapy|April 9, 2008
Antidepressant use in nonmajor depression: secondary analysis of a program to encourage active, rewarding lives for seniors (PEARLS), a randomized controlled trial in older adults from 2000 to 2003Susan L Lakey, Shelly L Gray, Paul Ciechanowski, et al.
Pageof 14

Showing results (11-20 of 131) with videos related to

Sort By:
Pageof 14
The American Journal of Geriatric Pharmacotherapy|November 24, 2004
Can clinical pharmacy services have a positive impact on drug-related problems and health outcomes in community-based older adults?Joseph T Hanlon, Catherine I Lindblad, Shelly L Gray
The American Journal of Geriatric Pharmacotherapy|November 24, 2004
Zolpidem prescribing and adverse drug reactions in hospitalized general medicine patients at a Veterans Affairs hospitalJane E Mahoney, Melissa J Webb, Shelly L Gray
The American Journal of Geriatric Pharmacotherapy|November 8, 2011
Medication use and functional status decline in older adults: a narrative reviewEmily P Peron, Shelly L Gray, Joseph T Hanlon
Journal of Managed Care & Specialty Pharmacy|December 24, 2025
Health care resource utilization and costs of commercially insured US patients with atopic dermatitis switching from first-line to second-line systemic targeted therapiesKevin H Li, Shelly L Gray, Sean D Sullivan
Pharmacoepidemiology and Drug Safety|August 28, 2020
Alzheimer's disease and related dementias risk: Comparing users of non-selective and M3-selective bladder antimuscarinic drugsDouglas Barthold, Zachary A Marcum, Shelly L Gray, et al.
Drugs & Aging|September 13, 2023
Systematic Review and Meta-analysis of Interventions to Reduce Adverse Drug Reactions in Older Adults: An UpdateShelly L Gray, Subashan Perera, Tim Soverns, et al.
ACR Open Rheumatology|October 24, 2022
Optimizing Medication Use in Older Adults With Rheumatic Musculoskeletal Diseases: Deprescribing as an Approach When Less May Be MoreJiha Lee, Namrata Singh, Shelly L Gray, et al.
Drugs & Aging|February 5, 2021
Interventions to Reduce Fall-Risk-Increasing Drug Use to Prevent Falls: A Narrative Review of Randomized TrialsShelly L Gray, Zizi Elsisi, Elizabeth A Phelan, et al.
Journal of the American Geriatrics Society|December 1, 2023
Medication use quality and safety in older adults: 2022 updateShelly L Gray, Nicole Brandt, Kenneth E Schmader, et al.
The American Journal of Geriatric Pharmacotherapy|April 9, 2008
Antidepressant use in nonmajor depression: secondary analysis of a program to encourage active, rewarding lives for seniors (PEARLS), a randomized controlled trial in older adults from 2000 to 2003Susan L Lakey, Shelly L Gray, Paul Ciechanowski, et al.
Pageof 14